Cardiovascular Disease Prevention for Psoriasis and Psoriatic Arthritis

Joel M Gelfand

Funded by the National Psoriasis Foundation’s Psoriasis Prevention Initiative (PPI), the goal of CP3 is to increase the lifespan and health of individuals living with psoriatic disease by decreasing barriers to appropriate CVD prevention care per guidelines from the American Academy of Dermatology (AAD)/National Psoriasis Foundation (NPF) and the American Heart Association(AHA)/American College of Cardiology(ACC), which target psoriasis patients as a population needing enhanced CVD prevention efforts